Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Alogliptin helps stimulate the release of insulin after a meal, which leads to better blood sugar control.” Mary Parks, M.D., director of the Division of Metabolism and Endocrinology Products in ...